ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,101.24
      -0.29%
      US Tech 100
      21,156.80
      -0.70%
      Dow Jones
      44,424.25
      -0.32%
      Brent Oil
      77.625
      0.00%
      Bitcoin
      105,030.00
      0.29%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Nicox Sa (0RCQ) Quote

      Nicox Sa

      Nicox Sa (0RCQ)

      LSE
      5.67
      0.00
      (0.00%)
      Closed January 26 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      5.67
      Bid
      5.53
      Ask
      5.81
      Volume
      2,139
      0.00 Day's Range 0.00
      5.67 52 Week Range 5.67
      Market Cap
      284.464M
      Previous Close
      5.67
      Open
      -
      Last Trade
      1653
      @
      0.303
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      7,468
      Shares Outstanding
      50,170,000
      Dividend Yield
      -
      PE Ratio
      -13.62
      Earnings Per Share (EPS)
      -0.42
      Revenue
      7.14M
      Net Profit
      -20.88M

      About Nicox Sa

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.nicox.com
      Headquarters
      Antibes, Alpes-maritimes, Fra
      Founded
      -
      Nicox Sa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0RCQ. The last closing price for Nicox was 5.67 €. Over the last year, Nicox shares have traded in a share price range of 5.67 € to 5.67 €.

      Nicox currently has 50,170,000 shares outstanding. The market capitalization of Nicox is 284.46 € million. Nicox has a price to earnings ratio (PE ratio) of -13.62.

      Ask ADVFN Intelligence (AI)

      0RCQ Latest News

      More News

      Nicox confirme son éligibilité au PEA-PME

      Nicox confirme son éligibilité au PEA-PME Communiqué de presseNicox confirme son éligibilité au PEA-PME22 janvier 2025 – publication à 7H30Sophia Antipolis, FranceNicox SA (Euronext Growth Paris :...

      January 22 2025
      UK Regulatory

      Nicox : Point d’activité et résumé financier du quatrième trimestre 2024

      Nicox : Point d’activité et résumé financier du quatrième trimestre 2024 Communiqué de presseNicox : Point d’activité et résumé financier du quatrième trimestre 2024  Recrutement du dernier...

      January 21 2025
      UK Regulatory

      Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights

      Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Press Release Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Last patient recruited in the...

      January 21 2025
      UK Regulatory

      Nicox annonce la première vente commerciale de ZERVIATE en Chine par son partenaire Ocumension, création d’une nouvelle source de revenus récurrents

      Nicox annonce la première vente commerciale de ZERVIATE en Chine par son partenaire Ocumension, création d’une nouvelle source de revenus récurrents Communiqué de presseNicox annonce la première...

      December 04 2024
      UK Regulatory

      Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream

      Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream Press Release Nicox Announces First Commercial Sale of ZERVIATE in China...

      December 04 2024
      UK Regulatory

      Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470

      Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470 Communiqué de presseNicox : Recrutement de patients achevé plus tôt que prévu...

      December 02 2024
      UK Regulatory

      Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected

      Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Press ReleaseNicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Confirms...

      December 02 2024
      UK Regulatory

      Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470

      Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470 Communiqué de presseNicox annonce la publication de la partie adaptive de l’étude clinique...

      November 19 2024
      UK Regulatory

      Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial

      Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial Press Release Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc...

      November 19 2024
      UK Regulatory

      Nicox : Point financier sur le troisième trimestre 2024 et résultats financiers du premier semestre 2024

      Nicox : Point financier sur le troisième trimestre 2024 et résultats financiers du premier semestre 2024 Communiqué de presseNicox : Point financier sur le troisième trimestre 2024 et résultats...

      October 17 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1005.675.675.676625.67DE
      4005.675.675.6732455.67DE
      12005.675.675.6774685.67DE
      26005.675.675.6764845.67DE
      52005.675.675.6733075.67DE
      156005.675.675.6728315.67DE
      260005.675.675.6728305.67DE

      0RCQ - Frequently Asked Questions (FAQ)

      What is the current Nicox share price?
      The current share price of Nicox is 5.67 €
      How many Nicox shares are in issue?
      Nicox has 50,170,000 shares in issue
      What is the market cap of Nicox?
      The market capitalisation of Nicox is EUR 284.46M
      What is the 1 year trading range for Nicox share price?
      Nicox has traded in the range of 5.67 € to 5.67 € during the past year
      What is the PE ratio of Nicox?
      The price to earnings ratio of Nicox is -13.62
      What is the cash to sales ratio of Nicox?
      The cash to sales ratio of Nicox is 39.85
      What is the reporting currency for Nicox?
      Nicox reports financial results in EUR
      What is the latest annual turnover for Nicox?
      The latest annual turnover of Nicox is EUR 7.14M
      What is the latest annual profit for Nicox?
      The latest annual profit of Nicox is EUR -20.88M
      What is the registered address of Nicox?
      The registered address for Nicox is SUNDESK SOPHIA ANTIPOLIS ,EMERALD SQUARE, B��TIMENT C, RUE EVARISTE GALOIS, BIOT, ANTIBES, ALPES-MARITIMES, 06410
      What is the Nicox website address?
      The website address for Nicox is www.nicox.com
      Which industry sector does Nicox operate in?
      Nicox operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      PPSProton Motor Power Systems Plc
      0.325p
      (85.71%)
      		4.07M
      CTAICatenai Plc
      0.255p
      (34.21%)
      		79.48M
      MILAMila Resources Plc
      0.23p
      (31.43%)
      		27.89M
      SNGSynairgen Plc
      2.34p
      (26.66%)
      		6.36M
      GILDGuild Esports Plc
      0.05p
      (25.00%)
      		34.84M
      QEDQuadrise Plc
      4.01p
      (-31.10%)
      		213.11M
      EMEEmpyrean Energy Plc
      0.1075p
      (-23.21%)
      		305.19M
      EXREngage Xr Holdings Plc
      1.55p
      (-20.92%)
      		12.64M
      RNWHRenew Holdings Plc
      720.00p
      (-20.79%)
      		2.45M
      UKRUkrproduct Group Limited
      2.00p
      (-20.00%)
      		1.25k
      PREMPremier African Minerals Limited
      0.0245p
      (-2.00%)
      		2.6B
      TRPTower Resources Plc
      0.0295p
      (7.27%)
      		1.07B
      EMEEmpyrean Energy Plc
      0.1075p
      (-23.21%)
      		305.19M
      QEDQuadrise Plc
      4.01p
      (-31.10%)
      		213.11M
      RRRRed Rock Resources Plc
      0.0525p
      (-4.55%)
      		198.76M

      Discussion

      View Full Feed
      GBR GBR 2 minutes ago
      chatgpt was released in late 2022, and created a firestorm.

      RS took over in January 2023. Why do you think it is that when RS took over they stopped talking about aiWARE. Even had an interview with Al Brown back in 2023, and he said nothing about aiWare capabilities.

      VERI
      trunkmonk trunkmonk 2 minutes ago
      ditto that and bump. like Ripple CEO said, they are doing things no one in the public knows about, it not just a game changer, it will change every ones lives soon, like it or not, care or not, believe it or not.
      https://www.tronweekly.com/robinhood-and-bitstamp-drive-xrp-ledger/
      XRPUSD
      $PennyMover $PennyMover 4 minutes ago
      2025 looks strong for Green Leaf - recap

      Golden Cross has put out the catalyst for GRLF which if you figure the market cap puts this near .004 a share
      See Below:

      https://media.stocktwits-cdn.com/api/3/media/1530389/medium.gif

      Thus far there was a q
      GRLF
      HoldEm777 HoldEm777 5 minutes ago
      I have papers... Lmfao. Certified bama boy.
      Unlike Mexedia having certified papers for the Phonetime aquisition .👀 But good looking out 👊
      RDAR
      sab63090 sab63090 6 minutes ago
      Ok, thanks but no conditional approval with a phase 4 either?
      AVXL
      trunkmonk trunkmonk 7 minutes ago
      does it matter, and who do you think the final decision makers are?
      FNMA
      eastunder eastunder 7 minutes ago
      XYZ

      1-21-25

      89.50

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175716900 Block Inc (Nyse: XYZ)

      www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=XYZ&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&a
      XYZ
      badog badog 7 minutes ago
      Remember Einstein's definition of going down the same road over and over and expecting a different outcome.

      Badog
      ERHE
      badog badog 7 minutes ago
      Remember the definition of going down the same road over and over and expecting a different outcome.

      Badog
      ERHE
      tdbowieknife tdbowieknife 7 minutes ago
      There were several complaints that that lab was not following procedures for containment before the pandemic started. It was very likely an employee/employees that walked out with it.

      https://www.businessinsider.com/us-officials-raised-alarms-about-safety-issues-in-wuhan-lab-report-2
      sharkey1 sharkey1 8 minutes ago
      Another lead for Kirko, this time Western Mass.

      https://www.msn.com/en-us/health/other/pharmacies-continue-to-see-shortage-of-adhd-medications/ar-AA1xG2ce
      ELTP
      Bubae Bubae 10 minutes ago
      Yes, press release / shareholder letter and Mexedia said... right there you have to stop. I have shown why their press releases can't be trusted with the filings several times. Lets just talk about the Mededia earing numbers and you will understand why they are here selling shares. True, those two
      RDAR
      sab63090 sab63090 10 minutes ago
      Yes, as I also said! It’s actually hard to accept therefore I will stick with the peer thinking that we really have something worthwhile! I’m traveling so this is from my phone
      AVXL
      MetaMonster MetaMonster 12 minutes ago
      Hail the holy grail breakthrough at all levels in the clinic, Hail the biggest discovery in research history of mankind
      RNAZ
      eastunder eastunder 12 minutes ago
      Block Announces Ticker Symbol Change to XYZ; To Report Fourth Quarter Results
      January 09, 2025 04:05 PM Eastern Standard Time

      DISTRIBUTED-WORK-MODEL/OAKLAND, Calif.--(BUSINESS WIRE)--Block, Inc. (NYSE: SQ) announced today that it will be changing its ticker symbols from “SQ” an
      XYZ
      RMS555 RMS555 13 minutes ago
      Once again you are making very false statements about KEGS....... KEGS is profitable and has been profitable in the 2nd Quarter and 3rd Quarter of 2024. The purchase of the new restaurant/bar almost tripled sales for KEGS. KEGS cash on hand has increased also.

      So your statement of: "T
      KEGS
      ksquared ksquared 14 minutes ago
      Michael Goodwin: Trump is already hitting the ground running as his first 100 days in office are off to a historic start
      By Michael Goodwin
      Published Jan. 25, 2025, 8:44 p.m. ET Buckle up, America.
      The trip back to common sense is just getting starte
      KVM KVM 16 minutes ago
      Over the years Veri had plenty of applications ie Ask Veri, Veriverse etc that were promoted and nothing ever became of them. Aiware and DMH are only ones that have seemed to stuck. DMH not a real money maker and IMO has growing competition. Aiware hasn't generated any revenues or interest that we k
      VERI
      MetaMonster MetaMonster 16 minutes ago
      The world is watching TTX --FDA fast track approval--Burn short motherfuckers burn in hell where you all belong
      RNAZ
      fredscott36 fredscott36 17 minutes ago
      ......ya got a hip hop street dancing rapper, mayor of the murder capital of the usa...............TOTALLY beating up on dozens and dozens of high-priced lawyers, and perps with $1.1-trillion in idle cash...........................BEYOND WEIRD................and the FDIC is simply trying to capitali

      Your Recent History

      LSE
      0RCQ
      Nicox
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads